A.E.R.C.H. Boonen

Bakker, N. F., Knoop, J., Van Den Hout, W. B., Hutting, N., Engels, J. A., Staal, J. B., Van Der Leeden, M., Boonen, A., Willemze, A., Nurmohamed, M. T., Vliet Vlieland, T. P. M., Gademan, M. G. J., & Van Weely, S. F. E. (2025). Effectiveness and cost-effectiveness of a multimodal, physiotherapist-led, vocational intervention for people with rheumatoid arthritis or axial spondyloarthritis and a reduced work ability: a randomized, controlled trial. Rheumatology International, 46(1), Article 11. https://doi.org/10.1007/s00296-025-06016-w

Calixto, O.-J., Baraliakos, X., Bautista-Molano, W., Boonen, A., van Kuijk, S., Essers, I., Lopez-Medina, C., Dougados, M., & Kiltz, U. (2025). Evaluation of spondyloarthritis-specific health utility based on ASAS health index (U-ASAS-HI) among the disease subtypes: an ancillary analysis from the ASAS-PerSpA study. RMD Open, 11(4), Article e005981. https://doi.org/10.1136/rmdopen-2025-005981

Zhao, S. S., Webers, C., Nikiphorou, E., van der Heijde, D., Braun, J., Kiltz, U., Ramiro, S., & Boonen, A. (2025). Disease activity and mental health symptoms in axial spondyloarthritis: concordant or discordant? Rheumatology, (1), Article keaf506. Advance online publication. https://doi.org/10.1093/rheumatology/keaf506

Raskin, N., Hiligsmann, M., Rebutoc, A. R., Bansback, N., Boonen, A., Buchbinder, R., Falahee, M., Fraenkel, L., Marshall, D. A., Maxwell, L., Nieuwlaat, R., Proulx, L., Saadat, P., Shea, B., Tugwell, P., Wiercioch, W., Beaton, D., Richards, P., Schünemann, H., ... Hazlewood, G. S. (2025). Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of OMERACT Health Outcome Descriptors. Seminars in Arthritis and Rheumatism, 74, Article 152769. https://doi.org/10.1016/j.semarthrit.2025.152769

Lindenburg, I. T. M., Boonen, A. E. R. C. H., Fakkert, I. E., van Zelm, V., & de Kock, K. A. (2025). Arbeidsgerichte zorg. Nederlands Tijdschrift voor Geneeskunde, 169, Article D8629.

Truijen, S. P. M., Boonen, A., Kallen, C. J. H. V. D., Koster, A., Bosma, H., & Onna, M. V. (2025). The impact of older age on the relation between chronic musculoskeletal pain and health-related quality of life: The Maastricht Study. Joint Bone Spine, 92(6), Article 105955. https://doi.org/10.1016/j.jbspin.2025.105955

Truijen, S. P. M., Boonen, A., van der Kallen, C. J. H., Koster, A., & van Onna, M. (2025). Musculoskeletal pain in an ageing population: a cross-sectional analysis of the Maastricht study. Rheumatology International, 45(9), Article 200. https://doi.org/10.1007/s00296-025-05961-w

Lopez-Medina, C., Capelusnik, D., Webers, C., van den Bosch, F., Boonen, A., Carron, P., Molto, A., & Ramiro, S. (2025). Measurement properties of disease activity instruments in peripheral spondyloarthritis: a post-hoc analysis of the CRESPA trial. RMD Open, 11(3), Article e005525. https://doi.org/10.1136/rmdopen-2025-005525

Kiltz, U., Moltó, A., van der Heijde, D., Bessette, L., Boonen, A., Bolce, R., Sapin, C., Gibble, T. H., Janos, B., Kronbergs, A., Ng, K. J., & Braun, J. (2025). Discriminating capacity of the ASAS health index in patients with axial spondyloarthritis treated with ixekizumab. Seminars in Arthritis and Rheumatism, 74, Article 152777. https://doi.org/10.1016/j.semarthrit.2025.152777

Calixto, O.-J., Kiltz, U., Bautista-Molano, W., Boonen, A., van Kuijk, S., Essers, I., van der Heijde, D., Braun, J., & Baraliakos, X. (2025). Performance of spondyloarthritis-specific health utilities based on the ASAS Health Index: an ancillary analysis from the ASAS-HI validation study. Rheumatology, 64(6), 3526-3533. Article keaf056. https://doi.org/10.1093/rheumatology/keaf056